Edition:
United Kingdom

Biolife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

17.53USD
19 Jul 2019
Change (% chg)

$0.56 (+3.30%)
Prev Close
$16.97
Open
$16.95
Day's High
$17.64
Day's Low
$16.84
Volume
46,667
Avg. Vol
52,792
52-wk High
$26.28
52-wk Low
$9.19

Latest Key Developments (Source: Significant Developments)

Casdin Capital To Become Shareholder In Biolife Solutions
Monday, 9 Apr 2018 

April 9 (Reuters) - BioLife Solutions Inc ::CASDIN CAPITAL TO BECOME SHAREHOLDER IN BIOLIFE SOLUTIONS.CASDIN CAPITAL LLC, ENTERED INTO AN AGREEMENT TO PURCHASE 1,000,000 BIOLIFE SOLUTIONS SHARES IN PRIVATE DEAL.  Full Article

Biolife Solutions Announces Preliminary 2017 Revenue Increase Of 34% To $11 Million
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS ANNOUNCES PRELIMINARY 2017 REVENUE INCREASE OF 34% TO $11 MILLION.Q4 REVENUE ROSE 39 PERCENT TO $3.1 MILLION.- FOR FULL YEAR 2017, PRELIMINARY REVENUE WAS $11 MILLION, A 34% INCREASE FROM 2016.- IN 2018, GROSS MARGIN IS EXPECTED TO RANGE BETWEEN 62% TO 64%.BIOLIFE SOLUTIONS - ‍FOR FY18 BIOPRESERVATION MEDIA REVENUE IS EXPECTED TO RANGE $13.6 MILLION -$14.7 MILLION, REPRESENTING GROWTH OF 25% TO 35% OVER 2017​.  Full Article

Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS.BIOLIFE SOLUTIONS - EXECUTED AGREEMENT TO SUPPLY CRYOSTOR CELL FREEZE MEDIA AND HYPOTHERMOSOL STORAGE AND SHIPPING MEDIA TO IOVANCE BIOTHERAPEUTICS.  Full Article

BioLife Solutions posts Q3 loss per share $0.03
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - BioLife Solutions Inc :Biolife Solutions announces third quarter 2017 financial results.Q3 loss per share $0.03.Biolife Solutions Inc - ‍gross margin for Q3 of 2017 was 63 pct compared with 57 pct in Q3 of 2016​.Biolife Solutions Inc - ‍2017 revenue is expected to range between $10.8 million to $11 million​.Biolife Solutions Inc - ‍2017 gross margin is expected to be between 60 pct and 62 pct​.Biolife Solutions Inc - qtrly ‍revenue $2.96 million versus $2.1 million.  Full Article

Biolife Solutions Q2 loss per share $0.06
Thursday, 10 Aug 2017 

Aug 10 (Reuters) - Biolife Solutions Inc :Biolife Solutions announces second quarter 2017 financial results.Sees FY 2017 revenue $10 million.Q2 loss per share $0.06.Biolife Solutions Inc says reaffirms full-year revenue guidance for biopreservation media products.  Full Article

BioLife Solutions executes supply agreement with Celyad for CryoStor
Monday, 31 Jul 2017 

July 31 (Reuters) - BioLife Solutions Inc :Biolife Solutions executes supply agreement with Celyad for CryoStor use in natural killer receptor based t-cell (nkr-t) platform targeting solid tumors and blood cancers.Biolife Solutions Inc - has executed a long term supply agreement with Celyad.Biolife Solutions Inc - co's CryoStor clinical grade cell freeze media is incorporated into Celyad's manufacturing process.  Full Article